NAVEC Investment Management
VC Fund
NAVEC Investment Management is an investment firm.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries NAVEC Investment Management invests in
Stages NAVEC Investment Management invests in
Countries NAVEC Investment Management invests in
Investment Focus
Industry
- Biotechnology 3 (60%)
- Therapeutics 1 (20%)
Stage
- Pre-Seed 4 (80%)
- Seed 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Epitome Therapeutics
|
Epitome Therapeutics is an early-stage biotechnology company developing CADENCE, a next-generation epigenome editing platform for precise, durable, and context-dependent control of gene expression without altering the underlying DNA sequence, with the aim of establishing a new therapeutic modality for diseases driven by dysregulated gene activity. | $2.3M / Pre-Seed / Jun 30, 2026 | |
Graph Therapeutics
|
Graph is a precision immunology techbio that leverages perturbation modeling from primary patient cell samples combined with multi-omics data to deliver transformative targeted therapies and biomarkers for immune-driven diseases. Graph believes that due to an incomplete understanding of complex immune-mediated diseases, millions of people are leftwithout adequate treatment options - and AI trained with complex disease data can solve this. | $5M / Seed / Jun 22, 2026 | |
Theorema
|
Theorema.ai is an AI-powered startup that focuses on autonomous R&D agents for science-intensive industries, including innovative materials, biotech, pharmaceuticals, and chemicals. | $3.3M / Pre-Seed / Mar 27, 2026 | |
Metri Bio
|
Metri Bio is a healthcare company that focused on endometrial diseases to improve lives of people. | $5M / Pre-Seed / Dec 02, 2025 | |
|
Graph Therapeutics
|
Graph is a precision immunology techbio that leverages perturbation modeling from primary patient cell samples combined with multi-omics data to deliver transformative targeted therapies and biomarkers for immune-driven diseases. Graph believes that due to an incomplete understanding of complex immune-mediated diseases, millions of people are leftwithout adequate treatment options - and AI trained with complex disease data can solve this. | $3.1M / Pre-Seed / Jan 09, 2025 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does NAVEC Investment Management invest in?
NAVEC Investment Management invests primarily in Biotechnology and Therapeutics startups, most often at Pre-Seed and Seed stage. Most of the 5 investments tracked by Shizune back companies in Austria. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did NAVEC Investment Management last invest?
The most recent investment recorded for NAVEC Investment Management closed in Jun 2026. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
